Home-Made Covid Vaccine Appeared to Work, but Questions Remained
By Kristen V Brown,
Bloomberg
| 10. 10. 2020
Josiah Zayner’s plan was simple: replicate a Covid-19 vaccine that had worked in monkeys, test it on himself and then livestream the experiment online over a period of months. Now, that improbable bid is over.
Around the world, dozens of Covid-19 vaccines are in human clinical trials involving tens of thousands of people. While vaccines typically take years to develop, U.S. scientists are racing to produce one in months through Operation Warp Speed. But Zayner, a one-time NASA researcher who left the scientific establishment in favor of engaging in do-it-yourself experiments, bet that by working outside regulatory structures, he could test a vaccine even more quickly and certainly more cheaply by giving it to himself.
Instead, Zayner discovered, testing a vaccine is far more complicated than he had imagined.
Even though his experiment yielded a promising result, Zayner found too many unanswered questions to say that it worked. For one, it wasn’t clear whether antibodies he found in his own body in extremely tiny measures before the experiment began made a difference. Zayner has long-believed that biohackers such as himself have the potential to make science move faster...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...